MedTrace Logo

Umbilical Cord Derived Wharton's Jelly for Knee Osteoarthritis

NCT04719793 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2022-07-21

No results posted yet for this study

Summary

The purpose of this study is to determine the safety and efficacy of intraarticular injection of umbilical cord derived Wharton's Jelly for treatment of knee osteoarthritis symptoms.

Conditions

  • Osteoarthritis, Knee

Interventions

BIOLOGICAL

Umbilical Cord-derived Wharton's Jelly

Intraarticular injection

Sponsors & Collaborators

  • BioIntegrate

    lead INDUSTRY

Principal Investigators

  • Saadiq F. El-Amin III, MD, PhD · El-Amin Orthopaedic & Sports Medicine Institute

  • Ashim Gupta, PhD, MBA · BioIntegrate

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-12-31
Completion
2024-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04719793 on ClinicalTrials.gov